Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. (Q40415499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Steven T. DeKosky

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

5

Jessica A Hoge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Julie C Price

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Brian J Lopresti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Xueling Lu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Scott K Ziolko

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Daniel P Holt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Carolyn C Meltzer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Chester A Mathis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cerebral Blood Flow & Metabolism

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1528-1547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944649%20AND%20SRC:MED&resulttype=core&format=json

A new look at the statistical model identification

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Evaluation of compartmental and spectral analysis models of [18F]FDG kinetics for heart and brain studies with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Spectral analysis of dynamic PET studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Mild cognitive impairment, amnestic type: an epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Absence of cognitive impairment or decline in preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

[11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Graphical analysis of PET data applied to reversible and irreversible tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

A strategy for removing the bias in the graphical analysis method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Spatial pattern analysis of functional brain images using partial least squares.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Parametric image reconstruction using spectral analysis of PET projection data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Serotonin 1A receptor binding and treatment response in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Intraclass correlations: uses in assessing rater reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

A direct approach to false discovery rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

On the Undecidability among Kinetic Models: From Model Selection to Model Averaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Thioflavine T interaction with amyloid β-sheet structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

A simple synthesis of [11C]methyl triflate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

Targeting alzheimer amyloid plaques in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600146

7 January 2021